The Senate unanimously passed into law research and public drug production, which aims to “promote accessibility” of drugs, vaccines and medical products.
The project, first presented in 2002 by Rep. Eduardo Makalu’s SI-declared “of national production research and public drug production, raw materials for the production of medicines, vaccines and medical products to the same understanding as real social.”
The initiative details to be considered public production laboratories of the “federal, provincial, municipal and autonomous city of Buenos Aires, the armed forces and state-run universities.”
The law’s objectives are to establish a reference framework for the production of essential medicines to the proposal of the World Health Organization (WHO) to promote research and development of public medicine.
This last point was desatacado ruling by Sen. Eric Calcagno, since “there are many orphan drugs that private laboratories do not produce, for example, are to prevent Changes disease.”
In turn, the radical senator and head of the Health Commission, José Cano, stressed the importance of “a standard to ensure the regionalization and optimization of human resources and technology” in health. It also stated that “there are 39 public manufacturing laboratories in 12 provinces.”
Meanwhile, the head of the ruling bloc, Miguel Angel Pickett, said the President had objected “strongly the enactment of this law, because there is a will of the Executive to give effect to this Act to consolidate and develop public laboratories.”
The project was approved by Parliament on 16 March and the Senate got favorable office of the Commission on Health and the Budget and Finance.
